ArticleFrontiers in microbiology2025
Panton-Valentine Leukocidin and concurrent respiratory viral infection as risk factors for fatal
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nursing management of deep vein thrombosis in children: a narrative review of challenges, evidence-based strategies, and systematic pathways.Translational pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: We conducted a retrospective cohort study of all SAB cases at our institution (Jan 2021-Mar 2025), expanding from an initial analysis of four fatal cases. Patient profiles, clinical characteristics and microbiological features were analyzed. Independent risk factors for mortality were determined through multivariate logistic regression. Results: Among 40 patients, mortality was higher in the community-associated Conclusion: PVL-producing strains, especially ST22, are key mortality drivers in SAB, with effects amplified by respiratory viral co-infection. Early recognition of PVL/viral co-infection and comorbidity management are critical for improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.